| Dr Annapoorani Arumugam, MD | |
|
106 Vision Park Blvd, Shenandoah, TX 77384-3000 | |
| (713) 442-1800 | |
| Not Available |
| Full Name | Dr Annapoorani Arumugam |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 19 Years |
| Location | 106 Vision Park Blvd, Shenandoah, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558673905 | NPI | - | NPPES |
| 326365903 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | P4139 (Texas) | Primary |
| 207Q00000X | Family Medicine | P4139 (Texas) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's The Woodlands Hospital | The woodlands, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kelsey-seybold Medical Group, Pllc | 9739093527 | 610 |
News Archive
More than one-third of children in the United States ages 6 to 19 years old are overweight or obese. Over the past 30 years, the number of obese adolescents has more than quadrupled, which also has led to an increase in children diagnosed with diabetes. To combat this trend, Aneesh Tosh, M.D., adolescent medicine physician at University of Missouri Health Care and associate professor of clinical child health at the MU School of Medicine, recommends that sugary drinks be removed from adolescents' diets.
Wanderlust in a person can be admirable or romantic. In a cancerous tumor, it may be lethal. Most deaths from cancer result from tumor cells that have strayed from their original location to insinuate their way into distant tissues. With few exceptions, however, doctors have little way of determining whether a newly formed tumor is more likely to remain idle or send invader cells to other parts of the body.
TRANSCEND SERVICES, INC., a leading provider of medical transcription services to the U.S. healthcare market, today announced its unaudited financial results for the fourth quarter and year ended December 31, 2009.
BaroFold, Inc. today announced that it has entered into an agreement to exclusively license its PreEMT™ Technology to Nuron Biotech for the development of BaroFeron™ and follow-on interferon beta products. BaroFeron is a proprietary recombinant human interferon beta being developed for the treatment of multiple sclerosis. Specific terms of the agreement are not disclosed.
PDL BioPharma, Inc. today announced that it has entered into a non-exclusive license agreement with Eli Lilly and Company under PDL's Queen et al patents with respect to teplizumab, a humanized anti-CD3 monoclonal antibody, as well as other potential next generation anti-CD3 molecules.
› Verified 9 days ago
| Entity Name | Kelsey-seybold Medical Group, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013915255 PECOS PAC ID: 9739093527 Enrollment ID: O20031117000204 |
News Archive
More than one-third of children in the United States ages 6 to 19 years old are overweight or obese. Over the past 30 years, the number of obese adolescents has more than quadrupled, which also has led to an increase in children diagnosed with diabetes. To combat this trend, Aneesh Tosh, M.D., adolescent medicine physician at University of Missouri Health Care and associate professor of clinical child health at the MU School of Medicine, recommends that sugary drinks be removed from adolescents' diets.
Wanderlust in a person can be admirable or romantic. In a cancerous tumor, it may be lethal. Most deaths from cancer result from tumor cells that have strayed from their original location to insinuate their way into distant tissues. With few exceptions, however, doctors have little way of determining whether a newly formed tumor is more likely to remain idle or send invader cells to other parts of the body.
TRANSCEND SERVICES, INC., a leading provider of medical transcription services to the U.S. healthcare market, today announced its unaudited financial results for the fourth quarter and year ended December 31, 2009.
BaroFold, Inc. today announced that it has entered into an agreement to exclusively license its PreEMT™ Technology to Nuron Biotech for the development of BaroFeron™ and follow-on interferon beta products. BaroFeron is a proprietary recombinant human interferon beta being developed for the treatment of multiple sclerosis. Specific terms of the agreement are not disclosed.
PDL BioPharma, Inc. today announced that it has entered into a non-exclusive license agreement with Eli Lilly and Company under PDL's Queen et al patents with respect to teplizumab, a humanized anti-CD3 monoclonal antibody, as well as other potential next generation anti-CD3 molecules.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Annapoorani Arumugam, MD 11511 Shadow Creek Pkwy, Pearland, TX 77584-7298 Ph: (713) 442-0000 | Dr Annapoorani Arumugam, MD 106 Vision Park Blvd, Shenandoah, TX 77384-3000 Ph: (713) 442-1800 |
News Archive
More than one-third of children in the United States ages 6 to 19 years old are overweight or obese. Over the past 30 years, the number of obese adolescents has more than quadrupled, which also has led to an increase in children diagnosed with diabetes. To combat this trend, Aneesh Tosh, M.D., adolescent medicine physician at University of Missouri Health Care and associate professor of clinical child health at the MU School of Medicine, recommends that sugary drinks be removed from adolescents' diets.
Wanderlust in a person can be admirable or romantic. In a cancerous tumor, it may be lethal. Most deaths from cancer result from tumor cells that have strayed from their original location to insinuate their way into distant tissues. With few exceptions, however, doctors have little way of determining whether a newly formed tumor is more likely to remain idle or send invader cells to other parts of the body.
TRANSCEND SERVICES, INC., a leading provider of medical transcription services to the U.S. healthcare market, today announced its unaudited financial results for the fourth quarter and year ended December 31, 2009.
BaroFold, Inc. today announced that it has entered into an agreement to exclusively license its PreEMT™ Technology to Nuron Biotech for the development of BaroFeron™ and follow-on interferon beta products. BaroFeron is a proprietary recombinant human interferon beta being developed for the treatment of multiple sclerosis. Specific terms of the agreement are not disclosed.
PDL BioPharma, Inc. today announced that it has entered into a non-exclusive license agreement with Eli Lilly and Company under PDL's Queen et al patents with respect to teplizumab, a humanized anti-CD3 monoclonal antibody, as well as other potential next generation anti-CD3 molecules.
› Verified 9 days ago
Dr. Chris Alan Sparkman, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 121 Vision Park Blvd Ste 110, Shenandoah, TX 77384 Phone: 936-224-4976 Fax: 832-995-5874 | |
Dr. Oluwadamilola Abisola Romiluyi, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 9250 Pinecroft Dr # N2.101, Shenandoah, TX 77380 Phone: 713-897-5539 | |
John Ford Franklin, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 9250 Pinecroft Dr, Shenandoah, TX 77380 Phone: 601-955-9201 | |
Dr. Kelechukwu Anne Olejeme, MD, MPH Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 17201 I H 45 S, Shenandoah, TX 77385 Phone: 936-270-2099 | |
Mr. Frederick I Njuki, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 286 Ed English Dr Ste B, Shenandoah, TX 77385 Phone: 281-764-1888 Fax: 281-419-3222 | |
Mr. James Camp, NP Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 9250 Pinecroft Dr Ste N2.101, Shenandoah, TX 77380 Phone: 713-897-2307 |